AcelRx Pharmaceuticals, Inc. Price Today
AcelRx Pharmaceuticals, Inc.
ACRX
Healthcare
$14.58M
💰
Market Cap
0
💸
Price to Earnings
$-2.8
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
0 |
Strong Buy |
0 |
Hold |
0 |
Sell |
0 |
Strong Sell |
0 |
ACRX Price Forecast Target
0.9 👉 5.0 +481%
ACRX EPS Forecast
-2.8 👉 -0.8 +-72%
Financials
Profit Margin
0 %
Revenue Growth
-76.9 %
Dividend
$ 0
Held Percent
2.6% - Insiders
38.9% - Institutions
58.5% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
Ron Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track re…
Bruce Berkowitz Portfolio
Bruce Berkowitz, the esteemed founder of Fairholme, has established himself as a prominent figure in the investment world with his exceptional portfolio strategy. Since its inception in 1999, Fairholme has grown into a formidable $19 billion mutual …
Chase Coleman Portfolio
Chase Coleman, the young and accomplished founder of Tiger Global, has made a significant impact in the investment world. With initial funding from Julian Robertson, Coleman's Tiger Global Management delivered impressive returns, including a remarka…
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…📮FAQ
Some Frequently Asked Questions.
The AcelRx Pharmaceuticals, Inc. industry is Drug Manufacturers - Specialty & Generic
The AcelRx Pharmaceuticals, Inc. sector is Healthcare
The AcelRx Pharmaceuticals, Inc. forecasted predicted Price to Earnings PE ratio is -1.1
The AcelRx Pharmaceuticals, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of AcelRx Pharmaceuticals, Inc. is $14.58M
There are total of 12029161 float shares with 38.9% held by Institutions and 2.6% held by insiders
The MAcelRx Pharmaceuticals, Inc. forecasted Earnings per Share EPS is $-0.8
The AcelRx Pharmaceuticals, Inc. Earnings per Share EPS is -2.8
The AcelRx Pharmaceuticals, Inc. company has $-3341000 gross profits with 0 profit margins
The AcelRx Pharmaceuticals, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The AcelRx Pharmaceuticals, Inc. Revenue is $370000 with -0.769 revenue growth
The price target for AcelRx Pharmaceuticals, Inc. stock is $5.0 for the high target and $4.2 for the low target
The consensus analyst recommendations for AcelRx Pharmaceuticals, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for AcelRx Pharmaceuticals, Inc. is Buy, with the following breakdown:
- Buy: 0
- Strong Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
The Beta of AcelRx Pharmaceuticals, Inc. is 0.5
The dividend of AcelRx Pharmaceuticals, Inc. is $0
The dividend yield of AcelRx Pharmaceuticals, Inc. is 0%
The biggest institutional and mutual fund holders of AcelRx Pharmaceuticals, Inc. stock are
The AcelRx Pharmaceuticals, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0